Pacific Biosciences of California (PACB) Surges: Stock Moves 14.4% Higher - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Pacific Biosciences of California, Inc. ( PACB ) was a big mover last session, as the company saw its shares rise by over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.87 to $5.98 in the past one-month time frame.

This medical instruments company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Pacific Biosciences of California currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Natus Medical Inc. ( BABY ), CryoLife Inc. ( CRY ) and DexCom, Inc. ( DXCM ). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

NATUS MEDICAL (BABY): Free Stock Analysis Report

CRYOLIFE INC (CRY): Free Stock Analysis Report

DEXCOM INC (DXCM): Free Stock Analysis Report

PACIFIC BIOSCI (PACB): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: BABY , CRY , DXCM , PACB

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by